BPC-157 and TB-500 also reduce inflammation in animal studies, but as a secondary effect of their tissue-repair pathways, not as a primary mechanism
LPCAT3, lysophosphatidylcholine acyltransferase 3
Optimising glycaemic control represents the most important disease-modifying intervention, with evidence demonstrating that improved HbA1c can slow neuropathy progression, though reversal of established nerve damage remains limited
IGF-1 LR3 in humans There are no published Phase 2 or Phase 3 human RCTs evaluating IGF-1 LR3 for body composition, fat loss, or muscle accretion in healthy or metabolically compromised adults
Individuals with active cancer or cancer history should avoid GH-elevating protocols
Likewise, in humans, some PAMPs, particularly those binding to TLR2, directly and indirectly increased the calcium mineralization and osteogenic differentiation of human FAPs isolated from muscles surrounding human NHO